Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMed Protection is a bioinformatics company that utilizes the proprietary Informational Spectrum Method (ISM) to analyze the biological functions of proteins and DNA. The company's "Electronic Biology" platform enables the characterization of molecular interactions based on physical-chemical properties, allowing for the prediction of vaccine effectiveness and the identification of drug resistance. BioMed Protection focuses primarily on infectious diseases, providing computational tools to monitor viral evolution and discover new therapeutic targets for pathogens such as SARS-CoV-2, influenza, and HIV. Their technology serves as a rapid screening tool for the design and optimization of biologics and small molecule drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMed Protection.